ROY DOUMANI Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ROY DOUMANI.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ROY DOUMANI. ROY DOUMANI is Director in CTI MOLECULAR IMAGING INC ($CTMI) and Director in Kite Pharma, Inc. ($KITE).
Latest Insider Trading Transactions of ROY DOUMANI
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 05 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Option Exercise | D | 91.21 | 8,810 | 803,560 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Option Exercise | D | 50.87 | 7,000 | 356,090 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Option Exercise | D | 59.23 | 10,000 | 592,300 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Option Exercise | D | 6.89 | 30,000 | 206,700 | 0 | |
Oct 05 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Sell | U | 180.00 | 25,065 | 4,511,700 | 0 | 25.1 K to 0 (-100.00 %) |
Oct 05 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Sell | D | 0.00 | 1,807 | 0 | 0 | 1.8 K to 0 (-100.00 %) |
Oct 05 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Sell | U | 180.00 | 150,620 | 27,111,600 | 1,807 | 152.4 K to 1.8 K (-98.81 %) |
Jun 22 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Option Exercise | A | 91.21 | 8,810 | 803,560 | 8,810 | |
Jun 22 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Grant | A | 0.00 | 2,410 | 0 | 152,427 | 150 K to 152.4 K (+1.61 %) |
Jun 09 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Sell | S | 84.53 | 5,000 | 422,634 | 150,017 | 155 K to 150 K (-3.23 %) |
Jun 09 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Sell | S | 84.46 | 10,000 | 844,621 | 155,017 | 165 K to 155 K (-6.06 %) |
Mar 02 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Option Exercise | M | 1.35 | 50,000 | 67,500 | 75,065 | |
Mar 02 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Buy | M | 1.35 | 50,000 | 67,500 | 75,065 | 25.1 K to 75.1 K (+199.48 %) |
Mar 02 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Sell | S | 76.77 | 2,800 | 214,942 | 25,065 | 27.9 K to 25.1 K (-10.05 %) |
Mar 02 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Sell | S | 77.03 | 6,000 | 462,200 | 115,017 | 121 K to 115 K (-4.96 %) |
Mar 02 2017 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Sell | S | 72.27 | 10,000 | 722,673 | 121,017 | 131 K to 121 K (-7.63 %) |
Jun 08 2016 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Sell | S | 58.38 | 4,000 | 233,516 | 27,865 | 31.9 K to 27.9 K (-12.55 %) |
Jun 08 2016 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Sell | S | 57.56 | 5,000 | 287,805 | 131,017 | 136 K to 131 K (-3.68 %) |
Jun 08 2016 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Sell | S | 58.25 | 5,000 | 291,260 | 136,017 | 141 K to 136 K (-3.55 %) |
Jun 03 2016 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Option Exercise | A | 50.87 | 7,000 | 356,090 | 7,000 | |
Jun 03 2016 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Grant | A | 0.00 | 1,950 | 0 | 141,017 | 139.1 K to 141 K (+1.40 %) |
Jun 17 2015 | KITE | Kite Pharma, Inc. | DOUMANI ROY | Director | Option Exercise | A | 59.23 | 10,000 | 592,300 | 10,000 | |
Jun 02 2004 | CTMI | CTI MOLECULAR IMAG ... | DOUMANI ROY | Director | Option Exercise | A | 0.00 | 3,859 | 0 | 8,859 | |
May 13 2004 | CTMI | CTI MOLECULAR IMAG ... | DOUMANI ROY | Director | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
May 04 2004 | CTMI | CTI MOLECULAR IMAG ... | DOUMANI ROY | Director | Option Exercise | A | 15.03 | 4,990 | 75,000 | 4,990 |
Page: 1